 Ionis Pharmaceuticals, Inc. NASDAQ:IONS Q3 2022 Earnings Conference Call November 9, 2022 11:30 AM ET Company Participants Julie Tepper - Investor Relations Brett Monia - Founder, CEO Director Richard Geary - EVP Chief Development Officer Elizabeth Hougen - EVP, Finance CFO Eric Swayze - EVP, Research Eugene Schneider - EVP Chief Clinical Development Officer Onaiza Cadoret - EVP, Chief Global Product Strategy Operations Officer Conference Call Participants Gary Nachman - BMO Capital Markets Yanan Zhu - Wells Fargo Myles Minter - William Blair Company Yale Jen - Laidlaw Company Brendan Smith - Cowen Joseph Stringer - Needham Company Gena Wang - Barclays Bank Jessica Fye - JPMorgan Chase Co. Operator Good morning, and welcome to the Ionis Pharmaceuticals Third Quarter 2022 Financial Results Conference Call. As a reminder, this call is being recorded. 